Related Experiment Video
Updated: Jul 6, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Akt activation protects pancreatic beta cells from AMPK-mediated death through stimulation of mTOR
Ying Cai1, Qidi Wang, Zhidong Ling
1Diabetes Research Center, Brussels Free University, VUB, Partner of the Juvenile Diabetes Research Center for Beta Cell Therapy in Europe, Laarbeeklaan 103, B-1090 Brussels, Belgium.
Abstract:
Sustained activation of AMP-activated protein kinase (AMPK) induces apoptosis in several cell types. In pancreatic beta cells this occurs under glucose limitation, or in the presence of the pharmacological AMPK activator 5-aminoimidazole-4-carboxamide-riboside (AICAR). It is unknown whether Akt activation can counteract AMPK-mediated apoptosis, nor whether mTOR activation downstream of Akt mediates any survival signal in these conditions. We report that expression of a constitutively active form of Akt increases mTOR activity and prevents apoptosis upon AMPK activation. Akt-mediated survival was inhibited by rapamycin. Expression of a constitutively active form of the mTOR target ribosomal protein S6 kinase (S6K) or of translation factor eIF4E reduced apoptosis by glucose limitation, and co-expression of S6K and eIF4E protected beta cells to the same extent as active Akt. The protective effects of active Akt and S6K were associated with increased cellular protein synthesis activity. It is concluded that Akt stimulation of mTOR and subsequent activation of the targets by which mTOR affects protein translation are required and sufficient mechanisms for Akt-mediated survival of beta cells undergoing sustained AMPK activation.
Insights
Sustained AMP-activated protein kinase (AMPK) activation triggers apoptosis in pancreatic beta cells. Akt activation, via mTOR and protein synthesis, promotes beta cell survival against AMPK-induced cell death.
Area of Science:
- Cell Biology
- Metabolic Signaling
- Endocrinology
Background:
- AMP-activated protein kinase (AMPK) activation induces apoptosis in pancreatic beta cells, particularly under glucose limitation or with AICAR treatment.
- The role of Akt and its downstream target mTOR in counteracting AMPK-mediated apoptosis in beta cells remains unclear.
Purpose of the Study:
- To investigate whether Akt activation can prevent AMPK-induced apoptosis in pancreatic beta cells.
- To determine if mTOR activation mediates the survival signals downstream of Akt in these conditions.
Main Methods:
- Utilized expression of constitutively active Akt and mTOR targets (S6K, eIF4E) in pancreatic beta cells.
- Administered AICAR to activate AMPK and rapamycin to inhibit mTOR.
- Assessed apoptosis rates and cellular protein synthesis activity.
Main Results:
- Constitutively active Akt increased mTOR activity and prevented apoptosis induced by AMPK activation.
- Akt-mediated survival was blocked by rapamycin, indicating mTOR dependence.
- Activating mTOR targets S6K or eIF4E reduced apoptosis, with combined expression mimicking active Akt's protective effect.
- Protective effects correlated with enhanced cellular protein synthesis.
Conclusions:
- Akt-mediated survival in pancreatic beta cells under sustained AMPK activation requires mTOR signaling.
- Activation of mTOR targets involved in protein translation is sufficient for Akt-mediated beta cell survival.
- This pathway highlights a critical mechanism for beta cell protection against metabolic stress.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
cAMP-dependent Protein Kinase Pathways
The JAK-STAT Signaling Pathway
MAPK Signaling Cascades
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are co-secreted in...
